Star Lake Bioscience Co.,Inc.

Star Lake Co., Inc. is a State-Owned public company established with Modern
enterprise system. The main business is microbial fermentation and biochemical
pharmaceuticals, which is specializing in nucleotides, amino acid and chemical  
synthesis materials, the main products are Inosine, L-Proline, Ribavirin, MSG,
IMP, GMP and I plus G as well as Guanosine, Adenosine, Tetra-acetylribose,  
Guanine, Hypoxanthine. All these products are exported to European, American and Asian countries; and the output of Inosine and L-Proline is the biggest in China,market share is 80% and 60% respectively, and export share is over 30%.

Flavouring of Nucleotide has filled in the empty of domestic new product,
and there will be a wide market and expectation. There are about 1,700 employees in corporation, including 400 technicians. The subordinates of Star Lake Co. Inc. include Zhaoqing Gourmet Powder Factory, Star Lake Biochemical Pharmaceutical Factory, Star Lake Biochemical Pharmaceutical No.2 Factory, Xinxing Shi Long Shan works, Amino acid technological research and develop center of Guangdong province, Guang Yi Real Estate Company, Marketing and Logistics Company and etc.

Its stock were put into market in Shanghai Securities Exchange in 1994, ever
since Star Lake has been insisting on developing the main business, based on the modern enterprise system, the market is regarded as the guide, profit maximum is regarded as target, Star Lake depends on its technological innovation and administration innovation, which will bring the advantage of biochemical project and technology into full play, to adjust industrial structure activety. Star Lake Co.,Inc., carries out its technology innovation strategy of less input, low risk, big output, good profit, and the finance is in good condition, combined index is better, which is regarded as earliest technology innovation advantageous enterprise and new-high technology enterprise. All fund raised from security exchange market has been put into the development of main business. About USD 13 millions of fund raised from stock market in 1997 had been put into the first stage construction of Star Lake Biochemical Pharmaceutical No. 2 Factory, around USD 28 millions of fund raised from stock market in August 1999 is also being put into the second stage construction of the Factory, the scale and profit of Star Lake will
be stepping forward a new stage. From now on, Star Lake will insist on developing microbial fermentation and biochemical project technology and administrative advantage, which stresses to cooperate with famous enterprises home and abroad,research unit and universities to build technology research center to develop biochemical and medicine products together, such as Nucleotide, Amino acid, Ocean creature active substances, new biochemical materials and etc., Star Lake is stepping forward splendid 21th century with its brand-new images of enterprise with modern high-tech.